Newsroom

Sorted by: Latest
-

Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb Announces Agreement with U.S. Government to Improve Affordability and Access to Critical Medicines for Americans...
-

Trends and Strategies Shaping the $4 Billion Narcolepsy Treatment Market, 2025-2032: Drug Classes, Disorder Types, Age Groups, Distribution Channels, Regions, Key Companies - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Narcolepsy Treatment Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. Senior leaders in the narcolepsy treatment market face an industry defined by technological advancement, shifting care expectations, and complex policy demands. Navigating this environment requires informed decision-making and operational agility to respond to rapid sector evolution. Narcolepsy Treatment Market Snapshot The global narcolepsy treatmen...
-

Swisslog Healthcare Appoints Maria Garces as Vice President of Product Management

BROOMFIELD, Colo.--(BUSINESS WIRE)--Swisslog Healthcare, a leading supplier of transport and pharmacy automation solutions, announces the appointment of Maria Garces as Vice President of Product Management. Garces brings deep experience in global product management, strategy, and business development across healthcare and technology sectors. In her new role, Garces will lead product management initiatives, develop strategic roadmaps, and drive innovation across Swisslog Healthcare's portfolio o...
-

Did You Lose Money in Perrigo Company? PRGO Stockholders Should Contact Robbins LLP for Information About Their Rights Against PRGO.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP: Company: Perrigo Company (NYSE: PRGO) provides over-the-counter health and wellness solutions in the U.S., Europe, and internationally. What is the class period? February 27, 2024 - November 4, 2025 What is the Case About? Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who acquired Perrigo securities during the class period because the Company allegedly misled investors regarding the value of its infant formula...
-

Did You Suffer Financial Loss in Skye Bioscience, Inc.? Stockholders Should Contact Robbins LLP for Information About Their Rights Against SKYE.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP: Company: Skye Bioscience, Inc. (NYSE: SKYE) is a clinical stage biopharmaceutical company that focuses on developing molecules that modulate G protein-coupled receptors (“GPCRs”) to treat obesity, overweight, and metabolic diseases. The Company’s lead product candidate is nimacimab. What is the class period? November 4, 2024 - October 3, 2025 What is the case about? Robbins LLP reminds stockholders that a class action was filed on behalf of all investors...
-

Location-Based Entertainment Market Forecast Report 2025-2030 - Integration of Big Data Analytics Platforms Capturing In-Venue Customer Behavior are Optimizing Attraction Layouts - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Location-Based Entertainment Market - Global Forecast 2025-2030" report has been added to ResearchAndMarkets.com's offering. The location-based entertainment market is rapidly transforming the guest experience landscape, blending immersive technologies, advanced analytics, and creative design to deliver interactive, narrative-driven environments. As venues and operators adapt to shifting audience expectations, this market presents new opportunities and operational...
-

Cintas Corporation annonce annonce ses résultats financiers du deuxième trimestre de l'exercice 2026

CINCINNATI--(BUSINESS WIRE)--Cintas Corporation (Nasdaq : CTAS) publie aujourd'hui les résultats de son deuxième trimestre de l'exercice 2026 clos le 30 novembre 2025. Le revenu du deuxième trimestre de l’exercice 2026 s’établit à 2,80 milliards de dollars, contre 2,56 milliards de dollars au deuxième trimestre de l’exercice précédent, soit une hausse de 9,3 %. La croissance du revenu au cours du trimestre a été positivement impactée de 0,7 % en raison des acquisitions. Le taux de croissance or...
-

JHX Deadline: Rosen Law Firm Urges James Hardie Industries plc (NYSE: JHX) Stockholders to Contact the Firm for Information About Their Rights

NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, reminds investors there is a class action lawsuit on behalf of purchasers of common stock of James Hardie Industries plc (NYSE: JHX) between May 20, 2025 through August 18, 2025, both dates inclusive (the “Class Period”). James Hardie provides exterior home and outdoor living solutions. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm i...
-

Have You Incurred Financial Losses Due to Jayud Global Logistics Limited Stock Drop? Contact Robbins LLP for Information About the Action You Can Take Against JYD.

SAN DIEGO--(BUSINESS WIRE)--Robbins LLP: Company: Jayud Global Logistics Limited (NASDAQ: JYD) claims to provide a range of worldwide cross-border supply chain solution services. What is the Class Period? April 21, 2023 - April 30, 2025 What is the case about? Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Jayud securities during the class period because the Company allegedly engaged in a fraudulent stock promotion s...
-

Merck Reaches Agreement With U.S. Government to Expand Access to Medicines and Lower Costs for Americans

RAHWAY, N.J.--(BUSINESS WIRE)--Merck Reaches Agreement With U.S. Government to Expand Access to Medicines and Lower Costs for Americans...